When you ensure your clinical trials are set up to enroll a representative patient population, you’re more likely to keep timelines and goals on track across your portfolio. ...
Within the FDA’s guidance document issued in August 2023: Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological ...
In 2022, the FDA provided draft guidance around diversity plans for sponsors to improve the enrollment of clinical trial participants from underrepresented racial and ethnic ...
In the last several decades, public health research has illuminated the considerable racial and ethnic disparities in the diagnosis, treatment, and outcomes of many cancers. In ...
.png?width=64&name=OST%20Transparent%20(1).png)
